Patents Assigned to Tsuzuki Educational Institute
  • Agent for treating or preventing cancer, and combination of RF pathway inhibitor and MEK inhibitor for treating or preventing cancer
    Patent number: 11925646
    Abstract: The present invention provides a method for treatment or prevention of cancer through novel action mechanism, namely, through inhibition of a riboflavin pathway. The method for treatment or prevention of cancer comprises administering an RF pathway inhibitor to a subject in need thereof.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: March 12, 2024
    Assignees: NATIONAL UNIVERSITY CORP. HOKKAIDO UNIVERSITY, Tsuzuki Educational Institute
    Inventors: Takako Ooshio, Masahiro Sonoshita, Satoshi Ichikawa, Yusuke Satoh, Kiyonaga Fujii